New York, NY – October 9, 2025, George Tetz participated as a panelist at the “3rd annual Clinical Trials in Rare Diseases conference” in Princeton, NJ
Last month, I attended the 3rd annual Clinical Trials in Rare Diseases conference, and had the opportunity to be a panelist alongside Bruce Bloom discussing the future of rare disease clinical trials. Notably, we talked about hashtagAI as it relates to therapeutic development (improving participant selection, reducing bias, optimising dosing), and how it can optimize the unprecedented amount of data we have in this golden age of biotechnology. Read more in Irena Maragkou’s write-up from Arena International Events Group
Using AI to forge the future of rare disease clinical trials